Development of a UV-Stabilized Topical Formulation of Nifedipine for the Treatment of Raynaud Phenomenon and Chilblains

Development of a UV-Stabilized Topical Formulation of Nifedipine for the Treatment of Raynaud Phenomenon and Chilblains

Raynaud’s Phenomenon is a vascular affliction resulting in pain and blanching of the skin caused by excessive and prolonged constriction of arterioles, usually due to cold exposure. Nifedipine is a vasodilatory calcium channel antagonist, which is used orally as the first-line pharmacologi...

Full description

Bibliographic Details
Main Authors: Ellen K. Wasan, Jinying Zhao, Joshua Poteet, Munawar A. Mohammed, Jaweria Syeda, Kevin Soulsbury, Jacqueline Cawthray, Amanda Bunyamin, Chi Zhang, Brian M. Fahlman, Ed S. Krol
Format: Article
Language:English
Published: MDPI AG 2019-11-01
Series:Pharmaceutics
Subjects:
nifedipine
emulsion
flavonoids
topical formulation
quercetin
photostabilizers
Online Access:https://www.mdpi.com/1999-4923/11/11/594

Internet

https://www.mdpi.com/1999-4923/11/11/594

Similar Items